PL1794190T3 - Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapii - Google Patents
Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapiiInfo
- Publication number
- PL1794190T3 PL1794190T3 PL05778354T PL05778354T PL1794190T3 PL 1794190 T3 PL1794190 T3 PL 1794190T3 PL 05778354 T PL05778354 T PL 05778354T PL 05778354 T PL05778354 T PL 05778354T PL 1794190 T3 PL1794190 T3 PL 1794190T3
- Authority
- PL
- Poland
- Prior art keywords
- epitopes
- tumour
- present
- immunotherapeutic methods
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04023546A EP1642905B1 (en) | 2004-10-02 | 2004-10-02 | Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| EP05778354A EP1794190B9 (en) | 2004-10-02 | 2005-09-09 | Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| PCT/EP2005/009719 WO2006037421A2 (en) | 2004-10-02 | 2005-09-09 | Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1794190T3 true PL1794190T3 (pl) | 2010-01-29 |
Family
ID=34926825
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04023546T PL1642905T3 (pl) | 2004-10-02 | 2004-10-02 | Epitopy immunogenicznych komórek pomocniczych T z antygenów guzów ludzkich oraz sposoby immunoterapeutyczne wykorzystujące te epitopy |
| PL05778354T PL1794190T3 (pl) | 2004-10-02 | 2005-09-09 | Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapii |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04023546T PL1642905T3 (pl) | 2004-10-02 | 2004-10-02 | Epitopy immunogenicznych komórek pomocniczych T z antygenów guzów ludzkich oraz sposoby immunoterapeutyczne wykorzystujące te epitopy |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8067529B2 (pl) |
| EP (2) | EP1642905B1 (pl) |
| JP (2) | JP2008514208A (pl) |
| AT (2) | ATE421533T1 (pl) |
| AU (1) | AU2005291660B2 (pl) |
| CA (1) | CA2583065A1 (pl) |
| DE (2) | DE602004019215D1 (pl) |
| ES (2) | ES2319286T3 (pl) |
| PL (2) | PL1642905T3 (pl) |
| SI (2) | SI1642905T1 (pl) |
| WO (1) | WO2006037421A2 (pl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0609121D0 (en) * | 2006-05-09 | 2006-06-21 | Univ Birmingham | Peptide Therapy |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| BRPI0814140A2 (pt) * | 2007-07-27 | 2017-03-28 | Immatics Biotechnologies Gmbh | composição de peptídeos associados a tumor e vacina anticâncer relacionada |
| TW200932260A (en) * | 2007-11-28 | 2009-08-01 | Oncotherapy Science Inc | STAT3 epitope peptides |
| TW201000119A (en) * | 2008-06-10 | 2010-01-01 | Oncotherapy Science Inc | MYBL2 epitope peptides and vaccines containing the same |
| AU2016204711B2 (en) * | 2008-10-01 | 2018-03-01 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors including neuronal and brain tumors |
| EP2172211B1 (en) * | 2008-10-01 | 2014-12-03 | Immatics Biotechnologies GmbH | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| AU2009301580B2 (en) * | 2008-10-06 | 2015-11-26 | The University Of British Columbia | Methods and systems for predicting misfolded protein epitopes |
| WO2011073215A2 (en) | 2009-12-14 | 2011-06-23 | Immatics Biotechnologies Gmbh | Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201009222D0 (en) | 2010-06-02 | 2010-07-21 | Immatics Biotechnologies Gmbh | Improved cancer therapy based on tumour associated antigens derived from cyclin D1 |
| NZ609916A (en) | 2010-12-14 | 2015-03-27 | Immatics Biotechnologies Gmbh | Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof |
| WO2014165282A1 (en) | 2013-03-12 | 2014-10-09 | Institute of Arthritis Research, LLC | Immunologically active polypeptide |
| CN110041403B (zh) | 2013-08-05 | 2023-03-10 | 伊玛提克斯生物技术有限公司 | 针对多种肿瘤例如包括nsclc在内的肺癌的新型免疫疗法 |
| ES2902835T3 (es) | 2014-01-09 | 2022-03-30 | Hadasit Med Res Service | Composiciones celulares mejoradas y métodos para la terapia contra el cáncer |
| EP3122375B1 (en) * | 2014-03-28 | 2021-03-03 | University of Washington through its Center for Commercialization | Breast and ovarian cancer vaccines |
| EP3126374B1 (en) * | 2014-04-01 | 2018-11-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An isolated donor mhc-derived peptide and uses thereof |
| JP2017515795A (ja) * | 2014-04-01 | 2017-06-15 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 単離されたドナーｍｈｃ由来ペプチド及びその使用 |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| ZA201707555B (en) * | 2015-06-25 | 2018-11-28 | Immatics Biotechnologies Gmbh | Novel cell epitopes and combination of cell epitopes for use in the immuno-therapy of myeloma and other cancers |
| MY198087A (en) * | 2015-10-05 | 2023-07-31 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
| GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201607535D0 (en) * | 2016-04-29 | 2016-06-15 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201521746D0 (en) | 2015-12-10 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers |
| MA45491A (fr) * | 2016-06-27 | 2019-05-01 | Juno Therapeutics Inc | Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés |
| WO2019155474A1 (en) | 2018-02-12 | 2019-08-15 | Hadasit Medical Research Services & Development Ltd. | Modulation of slamf6 splice variants for cancer therapy |
| EP3894543A1 (en) * | 2018-12-14 | 2021-10-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8cd45rc low tregs |
| WO2022189626A2 (en) * | 2021-03-11 | 2022-09-15 | Mnemo Therapeutics | Tumor neoantigenic peptides |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2103161A1 (en) * | 1991-05-16 | 1992-11-17 | David H. Beach | D-type cyclin and uses related thereto |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| US5912167A (en) * | 1995-06-06 | 1999-06-15 | Wisconsin Alumni Research Foundation | Autocatalytic cleavage site and use thereof in a protein expression vector |
| PT879282E (pt) | 1996-01-17 | 2003-11-28 | Imp College Innovations Ltd | Imunoterapia utilizando linfocitos t citotoxicos (ctl) |
| GB9823897D0 (en) * | 1998-11-02 | 1998-12-30 | Imp College Innovations Ltd | Immunotherapeutic methods and molecules |
| JP2005525788A (ja) * | 2001-09-28 | 2005-09-02 | インサイト・ゲノミックス・インコーポレイテッド | 酵素 |
| US20030194704A1 (en) * | 2002-04-03 | 2003-10-16 | Penn Sharron Gaynor | Human genome-derived single exon nucleic acid probes useful for gene expression analysis two |
| DE10225144A1 (de) * | 2002-05-29 | 2003-12-18 | Immatics Biotechnologies Gmbh | An MHC-Moleküle bindende Tumor-assoziierte Peptide |
| EP1369482A1 (en) * | 2002-06-07 | 2003-12-10 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Target genes for the diagnosis and treatment of cancer |
| CA2604852A1 (en) | 2005-04-15 | 2006-10-26 | Oncomethylome Sciences, S.A. | Methylation markers for diagnosis and treatment of cancers |
-
2004
- 2004-10-02 DE DE602004019215T patent/DE602004019215D1/de not_active Expired - Lifetime
- 2004-10-02 PL PL04023546T patent/PL1642905T3/pl unknown
- 2004-10-02 SI SI200431004T patent/SI1642905T1/sl unknown
- 2004-10-02 ES ES04023546T patent/ES2319286T3/es not_active Expired - Lifetime
- 2004-10-02 AT AT04023546T patent/ATE421533T1/de active
- 2004-10-02 EP EP04023546A patent/EP1642905B1/en not_active Expired - Lifetime
-
2005
- 2005-09-09 WO PCT/EP2005/009719 patent/WO2006037421A2/en active Application Filing
- 2005-09-09 DE DE602005015990T patent/DE602005015990D1/de active Active
- 2005-09-09 JP JP2007533893A patent/JP2008514208A/ja active Pending
- 2005-09-09 US US11/664,627 patent/US8067529B2/en not_active Expired - Fee Related
- 2005-09-09 ES ES05778354T patent/ES2328945T3/es active Active
- 2005-09-09 AU AU2005291660A patent/AU2005291660B2/en not_active Ceased
- 2005-09-09 EP EP05778354A patent/EP1794190B9/en not_active Not-in-force
- 2005-09-09 PL PL05778354T patent/PL1794190T3/pl unknown
- 2005-09-09 SI SI200530786T patent/SI1794190T1/sl unknown
- 2005-09-09 AT AT05778354T patent/ATE439375T1/de active
- 2005-09-09 CA CA002583065A patent/CA2583065A1/en not_active Abandoned
-
2011
- 2011-04-21 JP JP2011094758A patent/JP2011200231A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ATE421533T1 (de) | 2009-02-15 |
| EP1642905A1 (en) | 2006-04-05 |
| SI1642905T1 (sl) | 2009-04-30 |
| ES2328945T3 (es) | 2009-11-19 |
| EP1794190B9 (en) | 2010-05-19 |
| PL1642905T3 (pl) | 2009-04-30 |
| US8067529B2 (en) | 2011-11-29 |
| EP1794190B1 (en) | 2009-08-12 |
| DE602004019215D1 (de) | 2009-03-12 |
| SI1794190T1 (sl) | 2009-12-31 |
| ATE439375T1 (de) | 2009-08-15 |
| EP1642905B1 (en) | 2009-01-21 |
| AU2005291660B2 (en) | 2010-02-18 |
| WO2006037421A2 (en) | 2006-04-13 |
| US20090317428A1 (en) | 2009-12-24 |
| DE602005015990D1 (de) | 2009-09-24 |
| AU2005291660A1 (en) | 2006-04-13 |
| JP2008514208A (ja) | 2008-05-08 |
| JP2011200231A (ja) | 2011-10-13 |
| WO2006037421A3 (en) | 2006-06-29 |
| EP1794190A2 (en) | 2007-06-13 |
| ES2319286T3 (es) | 2009-05-06 |
| CA2583065A1 (en) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1794190T3 (pl) | Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapii | |
| HK1220709A1 (zh) | 混雜地結合於人類白細胞抗原 類分子的腫瘤相關肽 | |
| RS51893B (en) | TUMOR-ASSOCIATED PEPTIDES CONCERNING HUMAN LEUCOCYTIC ANTIGEN (HLA) CLASS I OR II MOLECULES AND ANTI-TUMOR VACCINE BASED ON THEM |